We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
BASFY Initiates Registration for the Adapzo Active Fungicide
Read MoreHide Full Article
Key Takeaways
BASFY begins registration for Adapzo, a new fungicide targeting Asian Soybean Rust.
Adapzo Active shows superior control over mutated fungal strains.
Regulatory dossiers are submitted in Brazil and Paraguay, with Bolivia to follow.
BASF SE (BASFY - Free Report) has started the registration of its new fungicide innovation, Adapzo Active, the industry’s first histone deacetylase inhibitor effective in controlling an unprecedented level of Asian Soybean Rust (ASR). BASF’s robust innovation pipeline has provided a much-needed solution for the farmers, considering that soybeans are becoming an increasingly relevant resource for food, feed and energy.
With 44% of its production located in Brazil, Paraguay and Bolivia, the regulatory dossiers were submitted to the authorities of the former two countries first and subsequently planned for Bolivia.
ASR has been significantly troublesome to soybean cultivators. The Adapzo Active product has outperformed existing products in providing ASR control. The fungicide works well with non-target species and fully controls mutated fungal strains. Adapzo’s full potential is obtained on usage with BASF’s complementary fungicides such as Pavecto Active.
BASFY stock has lost 2.6% over the past year compared with the industry’s 25.4% decline.
The Zacks Consensus Estimate for Akzo Nobel’s current-year earnings is pegged at $1.64 per share, implying a 17.14% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters while missing once.
The Zacks Consensus Estimate for NEM’s current-year earnings is pegged at $3.92 per share, indicating a 12.64% year-over-year rise.Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed once, with an average surprise of 32.41%. NEM’s shares have gained 40.1% in the past year.
The Zacks Consensus Estimate for BCPC’s 2025 earnings is pegged at $5.15 per share, indicating a rise of 31% from year-ago levels. The company’s earnings beat the consensus estimate in two of the trailing four quarters while missing the rest. Its shares have gained 8.8% in the past year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
BASFY Initiates Registration for the Adapzo Active Fungicide
Key Takeaways
BASF SE (BASFY - Free Report) has started the registration of its new fungicide innovation, Adapzo Active, the industry’s first histone deacetylase inhibitor effective in controlling an unprecedented level of Asian Soybean Rust (ASR). BASF’s robust innovation pipeline has provided a much-needed solution for the farmers, considering that soybeans are becoming an increasingly relevant resource for food, feed and energy.
With 44% of its production located in Brazil, Paraguay and Bolivia, the regulatory dossiers were submitted to the authorities of the former two countries first and subsequently planned for Bolivia.
ASR has been significantly troublesome to soybean cultivators. The Adapzo Active product has outperformed existing products in providing ASR control. The fungicide works well with non-target species and fully controls mutated fungal strains. Adapzo’s full potential is obtained on usage with BASF’s complementary fungicides such as Pavecto Active.
BASFY stock has lost 2.6% over the past year compared with the industry’s 25.4% decline.
Image Source: Zacks Investment Research
BASFY’s Zacks Rank & Key Picks
BASFY currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Akzo Nobel N.V. (AKZOY - Free Report) , Newmont Corporation (NEM - Free Report) and Balchem Corporation (BCPC - Free Report) . While AKZOY and NEM currently sport a Zacks Rank #1 (Strong Buy) each, BCPC carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Akzo Nobel’s current-year earnings is pegged at $1.64 per share, implying a 17.14% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters while missing once.
The Zacks Consensus Estimate for NEM’s current-year earnings is pegged at $3.92 per share, indicating a 12.64% year-over-year rise.Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed once, with an average surprise of 32.41%. NEM’s shares have gained 40.1% in the past year.
The Zacks Consensus Estimate for BCPC’s 2025 earnings is pegged at $5.15 per share, indicating a rise of 31% from year-ago levels. The company’s earnings beat the consensus estimate in two of the trailing four quarters while missing the rest. Its shares have gained 8.8% in the past year.